Detalhe da pesquisa
1.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer;
128(5): 877-885, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36482190
2.
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials.
Liver Int;
42(2): 458-467, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34826193
3.
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
Anticancer Drugs;
33(1): e781-e783, 2022 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34407053
4.
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
BMC Med Genet;
21(1): 225, 2020 11 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33208122
5.
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience.
Int J Hyperthermia;
37(1): 479-485, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32396398
6.
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone.
Anticancer Drugs;
30(4): 428-430, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30875350
7.
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients.
Oncology;
94(1): 7-11, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29024931
8.
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.
Liver Int;
38(2): 278-284, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28792650
9.
Microbiota, NASH, HCC and the potential role of probiotics.
Carcinogenesis;
38(3): 231-240, 2017 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28426878
10.
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
Oncologist;
21(5): 600-7, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27032872
11.
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention.
Hepatology;
65(3): 1075-1076, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28010045
12.
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis.
Curr Oncol;
30(3): 2613-2624, 2023 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36975412
13.
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Life (Basel);
13(11)2023 Nov 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38004310
14.
Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management.
Curr Oncol;
29(2): 1223-1236, 2022 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35200603
15.
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma.
Cancers (Basel);
14(19)2022 Sep 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36230538
16.
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Acta Biomed;
93(6): e2022268, 2022 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36533763
17.
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.
Expert Rev Gastroenterol Hepatol;
16(1): 73-79, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34890512
18.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index.
J Gastrointest Cancer;
53(3): 528-536, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34033000
19.
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index.
J Gastrointest Cancer;
53(2): 289-298, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33544375